Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT06048705 · TERMINATED
Trial details
- NCT number
- NCT06048705
- Sponsor
- Adaptimmune
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-09
- Primary completion
- 2023-06-08
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.